EMEA-002378-PIP01-18
Key facts
| Active substance |
N-hydroxy-5-methylfuran-2-sulfonamide (BMS-986231)
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0110/2019
|
| PIP number |
EMEA-002378-PIP01-18
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of acute heart failure
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Bristol-Myers Squibb International Corporation
Tel. +44 (0)1895 523740 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|